Table 4

Correlations between anthropometric data, clinical findings and bone density measurements in patients with psoriatic arthritis

Vertebral

Femur

TLM

TBF

BMD

BMD


Age r*

-0.05

-0.09

0.11

0.02

(P)

(0.76)

(0.53)

(0.45)

(0.86)

Weight r*

0.27

0.13

0.63

0.59

(P)

(0.78)

(0.39)

(<0.001)

(<0.001)

BMI r*

0.16

0.20

0.35

0.63

(P)

(0.30)

(0.17)

(0.02)

(<0.001)

Duration of Ps r*

0.23

0.02

0.13

-0.10

(P)

(0.13)

(0.88)

(0.37)

(0.52)

Duration of PsA r

0.14

0.09

0.14

0.15

(P)

(0.34)

(0.55)

(0.35)

(0.34)

Duration of menopause r

-0.29

-0.14

0.07

-0.04

(P)

(0.04)

(0.37)

(0.64)

(0.79)

HAQ r

0.04

0.01

-0.27

-0.02

(P)

(0.8)

(0.93)

(0.08)

(0.91)

PASI r

0.08

-0.13

0.13

-0.15

(P)

(0.6)

(0.39)

(0.38)

(0.31)

DAS 28 r*

-0.13

-0.19

-0.12

0.12

(P)

(0.39)

(0.2)

(0.41)

(0.43)

PsARC for swollen joints r

0.13

-0.16

-0.01

0.02

(P)

(0.41)

(0.29)

(0.94)

(0.88)

PsARC for painful joints r

-0.13

-0.03

0.07

0.01

(P)

(0.38)

(0.86)

(0.63)

(0.93)

PsARC (VAS) - patient r

0.05

-0.01

-0.15

0.08

(P)

(0.74)

(0.91)

(0.32)

(0.57)

PsARC (VAS) - physician r

0.01

0.01

-0.62

0.05

(P)

(0.93)

(0.94)

(0.69)

(0.75)

TLM r*

0.19

0.15

1

-0.22

(P)

(0.2)

(0.33)

(0.15)

TBF r*

0.11

-0.006

-0.22

1

(P)

(0.48)

(0.97)

(0.15)


r*, Pearson's correlation; r, Spearman's correlation

Pedreira et al. Arthritis Research & Therapy 2011 13:R16   doi:10.1186/ar3240

Open Data